Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 3Lymphoma, Follicular 2Leukemia 2Waldenstrom Macroglobulinemia 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, AIDS-Related 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1HIV Infections 1

Interventions

Cyclophosphamide 20fludarabine phosphate 16Peripheral Blood Stem Cell Transplantation 11Tacrolimus 10Mycophenolic Acid 10Whole-Body Irradiation 9Cyclosporine 8Methotrexate 7Etoposide 7Busulfan 7Antilymphocyte Serum 7Vincristine 6Prednisone 6Melphalan 6Doxorubicin 5Rituximab 4Transplantation 3Sirolimus 3Radiotherapy 3Methylprednisolone 3Gemcitabine 3Brentuximab Vedotin 3Alemtuzumab 3nelarabine 2merphos 2etoposide phosphate 2Therapeutics 2Prednisolone 2Panobinostat 2Lenalidomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Immunoblastic Lymphadenopathy × VAP-cyclo protocol × Clear all
NCT00079261 2012-09-24

Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
25 enrolled
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡